Allogene Therapeutics
ALLO
$2.97
Share price
1.71%
Change (1 day)
-44.49%
Change (1 year)
Categories
Allogene Therapeutics (ALLO) - Total assets
Total assets on the balance sheet as of December 2023 : $0.64 B
According to Allogene Therapeutics 's latest financial reports the company's total assets are $0.64 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Allogene Therapeutics - Total assets on balance sheet (from 2018 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.81 B | -21.33% |
| 2021-12-31 | $1.03 B | -15.41% |
| 2020-12-31 | $1.22 B | 71.05% |
| 2019-12-31 | $0.71 B | -7.24% |
| 2018-12-31 | $0.77 B | |
| 2017-12-31 | $N/A |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.25 B | -60.80% | 🇺🇸 USA |